Clinical Trial Review

By No Comments
SKIN CANCERA Tailored Internet Intervention to Reduce Skin Cancer Risk Behaviors Among Young Adults Skin cancer is the most common cancer in the United States, with over a million new…
Read More

Pipeline Previews

By No Comments
Lilly’s Taltz Eli Lilly and Company announced that the FDA has approved Taltz® (ixekizumab) injection 80 mg/mL for the treatment of moderate-to-severe plaque psoriasis in adult patients who are candidates…
Read More